Stage IV Adult Diffuse Large Cell Lymphoma

specific

Stage III: Involvement of lymph node regions on both sides of the diaphragm (III) that may also be accompanied by localized involvement of an extralymphatic organ or site (IIIE), by involvement of the spleen (IIIS), or both (IIIS+E). (from PDQ)

Centers

Active Trials

—

Cancer Funding

Top Centers for Stage IV Adult Diffuse Large Cell Lymphoma(20)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive	—	—	52.5
2	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive	—	—	52.5
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	52.5
4	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	—	52.5
5	OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive	—	—	52.5
6	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	—	52.5
7	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive	—	—	52.5
8	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	52.5
9	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	52.5
10	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive	—	—	52.5
11	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	52.5
12	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	52.5
13	Cleveland Clinic Cancer CenterCleveland, OH	—	—	52.5
14	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	—	52.5
15	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	—	—	52.5
16	University of Illinois Cancer CenterChicago, IL	—	—	52.5
17	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive	—	—	52.5
18	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive	—	—	52.5
19	Penn State Cancer InstituteHershey, PA	—	—	52.5
20	Princess Margaret Cancer CentreToronto, ON	—	—	52.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →